{"id":"https://openalex.org/W4391333767","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.612","title":"NEXT: A phase 2 study of nivolumab adjuvant to chemoradiation in patients (pts) with localized urothelial carcinoma.","display_name":"NEXT: A phase 2 study of nivolumab adjuvant to chemoradiation in patients (pts) with localized urothelial carcinoma.","publication_year":2024,"publication_date":"2024-01-29","ids":{"openalex":"https://openalex.org/W4391333767","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.612"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.4_suppl.612","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.612","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.4_suppl.612","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031760297","display_name":"Gliceida Galarza Fortuna","orcid":"https://orcid.org/0000-0002-1084-953X","observed_orcids":["https://orcid.org/0000-0002-1084-953X"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gliceida Galarza Fortuna","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059162411","display_name":"George Daniel Grass","orcid":"https://orcid.org/0000-0002-8417-5611","observed_orcids":["https://orcid.org/0000-0002-8417-5611"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Daniel Grass","raw_affiliation_strings":["Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022744341","display_name":"Benjamin Louis Maughan","orcid":"https://orcid.org/0000-0002-0010-8551","observed_orcids":["https://orcid.org/0000-0002-0010-8551"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin L. Maughan","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023152191","display_name":"Rohit Jain","orcid":"https://orcid.org/0000-0002-9295-9360","observed_orcids":["https://orcid.org/0000-0002-9295-9360"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rohit K. Jain","raw_affiliation_strings":["H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090253469","display_name":"Christopher Dechet","orcid":"https://orcid.org/0000-0002-0534-6006","observed_orcids":["https://orcid.org/0000-0002-0534-6006"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher B. Dechet","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071754471","display_name":"Julia Beck","orcid":"https://orcid.org/0000-0002-4143-1363","observed_orcids":["https://orcid.org/0000-0002-4143-1363","https://orcid.org/0009-0007-8556-1075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julia Beck","raw_affiliation_strings":["Chronix Biomedical, G\u00f6ttingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chronix Biomedical, G\u00f6ttingen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069783216","display_name":"Ekkehard Sch\u00fctz","orcid":"https://orcid.org/0000-0002-9639-4870","observed_orcids":["https://orcid.org/0000-0002-9639-4870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ekkehard Schuetz","raw_affiliation_strings":["OncoCyte, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoCyte, Irvine, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063526218","display_name":"Alejandro S\u00e1nchez","orcid":"https://orcid.org/0000-0002-9054-7346","observed_orcids":["https://orcid.org/0000-0002-9054-7346"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Sanchez","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054836663","display_name":"Brock B. O'Neil","orcid":"https://orcid.org/0000-0002-1497-5824","observed_orcids":["https://orcid.org/0000-0002-1497-5824"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brock ONeil","raw_affiliation_strings":["Hunstman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunstman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087611807","display_name":"Michael Adam Poch","orcid":"https://orcid.org/0000-0001-7339-8978","observed_orcids":["https://orcid.org/0000-0001-7339-8978"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Adam Poch","raw_affiliation_strings":["H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054735116","display_name":"Roger Li","orcid":"https://orcid.org/0000-0003-1274-7200","observed_orcids":["https://orcid.org/0000-0003-1274-7200"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Li","raw_affiliation_strings":["Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057200744","display_name":"Shane A. J. Lloyd","orcid":"https://orcid.org/0000-0002-4235-7652","observed_orcids":["https://orcid.org/0000-0002-4235-7652"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shane Lloyd","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040908498","display_name":"Jonathan David Tward","orcid":"https://orcid.org/0000-0001-7765-4473","observed_orcids":["https://orcid.org/0000-0001-7765-4473"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan David Tward","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070458204","display_name":"Tenzin Kunsang Phunrab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tenzin Kunsang Phunrab","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076648854","display_name":"Josiah Hawks","orcid":"https://orcid.org/0000-0001-9908-4598","observed_orcids":["https://orcid.org/0000-0001-9908-4598"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josiah Hawks","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034103357","display_name":"Umang Swami","orcid":"https://orcid.org/0000-0003-3518-0411","observed_orcids":["https://orcid.org/0000-0003-3518-0411"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umang Swami","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082070319","display_name":"Kenneth M. Boucher","orcid":"https://orcid.org/0000-0003-2833-0127","observed_orcids":["https://orcid.org/0000-0003-2833-0127"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth M. Boucher","raw_affiliation_strings":["Hunstman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunstman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100763587","display_name":"Neeraj Agarwal","orcid":"https://orcid.org/0000-0003-1076-0428","observed_orcids":["https://orcid.org/0000-0003-1076-0428","https://orcid.org/0000-0001-6574-8499"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neeraj Agarwal","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013942253","display_name":"Sumati V. Gupta","orcid":"https://orcid.org/0000-0001-6271-0831","observed_orcids":["https://orcid.org/0000-0001-6271-0831"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sumati Gupta","raw_affiliation_strings":["Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT","institution_ids":["https://openalex.org/I2801159745"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"4_suppl","first_page":"612","last_page":"612"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8700000047683716},{"id":"https://openalex.org/keywords/adjuvant-immunotherapy","display_name":"adjuvant immunotherapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8880000114440918},{"id":"https://openalex.org/keywords/bladder-preservation","display_name":"bladder preservation","score":0.7250000238418579},{"id":"https://openalex.org/keywords/failure-free-survival","display_name":"failure-free survival","score":0.9520000219345093},{"id":"https://openalex.org/keywords/copy-number-instability","display_name":"copy number instability","score":0.7049999833106995},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.765999972820282},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7049999833106995},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.593999981880188},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.6370000243186951},{"id":"https://openalex.org/keywords/local-recurrence","display_name":"local recurrence","score":0.5799999833106995},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9374219179153442},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7385340929031372},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6663216352462769},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6334003210067749},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5124707818031311},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40786442160606384},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4047360420227051},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.36003297567367554},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35899603366851807},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3365582525730133},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.12084615230560303}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.4_suppl.612","doi":"https://doi.org/10.1200/jco.2024.42.4_suppl.612","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2024.42.4_suppl.612","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408553793","https://openalex.org/W4212939704","https://openalex.org/W7204530084","https://openalex.org/W4410791548","https://openalex.org/W2761522084","https://openalex.org/W3163995648","https://openalex.org/W3172349060","https://openalex.org/W7160562956","https://openalex.org/W4243715246","https://openalex.org/W4413102884"],"abstract_inverted_index":{"612":[0],"Background:":[1],"Definitive":[2],"chemoradiation":[3],"(CRT)":[4],"is":[5,70],"the":[6,21,71,107,267,348,357],"preferred":[7],"bladder":[8],"preservation":[9],"treatment":[10],"for":[11,52,291,325,364],"non-metastatic":[12],"urothelial":[13],"cancer":[14],"(nmUC).":[15],"The":[16,135,321],"NEXT":[17],"trial":[18,416],"(NCT03171025)":[19],"evaluated":[20],"efficacy":[22,73,368],"of":[23,79,83,155,193,209,269,276,293,303,410],"adjuvant":[24],"nivolumab":[25,160,304,361],"to":[26,54,106,129,362],"definitive":[27],"CRT":[28,363],"in":[29,89,190,228,257,305,316,337,356,373,387,394,397,408],"pts":[30,39,132,259,307,317,326,338,374],"with":[31,94,287,318,339,352,369,375,381],"nmUC.":[32],"Methods:":[33],"This":[34,69],"multicenter":[35],"study":[36],"enrolled":[37],"nmUC":[38,365],"who":[40,327,412],"received":[41],"standard-of-care":[42],"CRT.":[43],"Nivolumab":[44],"480":[45],"mg":[46],"was":[47,104,119,138,169,181,272,285,308,329],"administered":[48],"every":[49],"4":[50],"weeks":[51],"up":[53],"12":[55],"doses.":[56],"Primary":[57],"endpoint:":[58,67],"failure-free":[59],"survival":[60],"(FFS)":[61],"at":[62,177,206],"2":[63,178,229],"years":[64],"(yrs).":[65],"Secondary":[66],"safety.":[68],"first":[72],"and":[74,81,87,112,166,216,253,347,385,402],"safety":[75],"analysis":[76],"after":[77],"completion":[78],"enrollment,":[80],"correlation":[82],"disease":[84,235,249],"risk":[85],"features,":[86],"changes":[88,346,393],"plasma":[90,102,388],"cell-free":[91],"DNA":[92,398],"(cfDNA)":[93],"outcomes.":[95],"Shallow":[96],"whole":[97],"genome":[98,110],"sequenced":[99],"data":[100,156],"from":[101,121],"cfDNA":[103,409],"mapped":[105],"human":[108],"reference":[109],"(HG19),":[111],"copy":[113,344,391],"number":[114,268,345,392],"instability":[115],"(CNI)":[116],"Score":[117],"(Oncocyte)":[118],"derived":[120],"statistically":[122],"significant":[123,274],"altered":[124],"regions.":[125],"Results:":[126],"From":[127],"8/03/2017":[128],"1/25/2023,":[130],"28":[131],"were":[133,162,212,255],"enrolled.":[134],"median":[136,159,167],"age":[137],"72":[139],"yrs":[140,179],"(range":[141,164,172,310,314,331,335],"54-86":[142],"yrs).":[143],"Ten":[144],"patients":[145],"(36%)":[146],"had":[147,196],"\u2265":[148],"T3":[149],"and/or":[150],"N+":[151],"disease.":[152,377],"At":[153],"time":[154],"cut-off":[157],"(9/14/23),":[158],"cycles":[161],"8.5":[163],"1-12),":[165],"follow-up":[168],"11":[170],"months":[171],"6":[173],"-":[174],"45).":[175],"FFS":[176],"(n=24)":[180],"38.7":[182],"%":[183],"(95%":[184,295],"CI":[185,296],"23%-65.2%).":[186],"Disease":[187,378],"relapse":[188,379],"occurred":[189,205,227],"16":[191],"pts,":[192],"which":[194],"9":[195,334],"local":[197],"recurrences.":[198],"Grade":[199,219],"\u22653":[200],"treatment-related":[201],"adverse":[202],"events":[203],"(AEs)":[204],"a":[207,262,273,288],"frequency":[208],"10.7%.":[210],"These":[211],"elevated":[213],"transaminases,":[214],"diarrhea,":[215],"polymyalgia":[217],"rheumatica.":[218],"3":[220],"radiation":[221],"therapy":[222],"oncology":[223],"group":[224],"(RTOG)":[225],"AEs":[226],"pts.":[230],"One":[231],"or":[232],"more":[233],"high-risk":[234,270,283,376,382],"features":[236,271,384],"(ie.":[237],"plasmacytoid":[238],"differentiation,":[239],"T4,":[240],"N+,":[241],"multiple":[242],"tumors,":[243],"tumors":[244],">":[245],"5":[246],"cm,":[247],"residual":[248],"before":[250],"CRT,":[251],"CIS,":[252],"hydronephrosis)":[254],"present":[256,407],"22":[258],"(79%).":[260],"In":[261],"Cox":[263],"proportional":[264],"hazards":[265],"model,":[266],"predictor":[275],"progression":[277,292,353],"(p":[278],"=":[279],"0.006).":[280],"Each":[281],"additional":[282],"feature":[284],"associated":[286,349,351],"hazard":[289],"ratio":[290],"1.77":[294],"1.17-2.67).":[297],"Median":[298],"CNI":[299,386],"(mCNI)":[300],"on":[301,323],"C1D1":[302],"relapsed":[306],"31":[309],"3-232)":[311],"vs.":[312,333],"24":[313],"3-109)":[315],"ongoing":[319,340],"response.":[320,341],"mCNI":[322],"C4D1":[324],"progressed":[328,413],"15.5":[330],"6-371)":[332],"3-65)":[336],"Oncogenic":[342,390],"gene":[343],"pathways":[350,405],"are":[354,406],"listed":[355],"table.":[358],"Conclusions:":[359],"Adjuvant":[360],"has":[366],"promising":[367],"tolerable":[370],"AEs,":[371],"even":[372],"correlates":[380],"clinical":[383],"cfDNA.":[389],"genes":[395],"involved":[396],"repair,":[399],"RTK-RAS-PI3K,":[400],"WNT,":[401],"cell":[403],"cycle":[404],"those":[411],"(Table).":[414],"Clinical":[415],"information:":[417],"NCT03171025":[418],".":[419],"[Table:":[420],"see":[421],"text]":[422]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-01-30T00:00:00"}